NEULAND LABORATORIES
Back to Balance Sheet
|
NEULAND LABORATORIES Last 5 Year Sundry Debtors History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Sundry Debtors | ₹316 Cr | ₹374 Cr | ₹362 Cr | ₹234 Cr | ₹218 Cr |
What is the latest Sundry Debtors ratio of NEULAND LABORATORIES ?
| Year | Sundry Debtors |
|---|---|
| Mar2025 | ₹316 Cr |
| Mar2024 | ₹374 Cr |
| Mar2023 | ₹362 Cr |
| Mar2022 | ₹234 Cr |
| Mar2021 | ₹218 Cr |
How is Sundry Debtors of NEULAND LABORATORIES Trending?
| Years | Sundry Debtors | % Change | |
|---|---|---|---|
| Mar2025 | ₹316 Cr | -15.48 | |
| Mar2024 | ₹374 Cr | 3.25 | |
| Mar2023 | ₹362 Cr | 54.39 | |
| Mar2022 | ₹234 Cr | 7.62 | |
| Mar2021 | ₹218 Cr | - | |
Compare Sundry Debtors of peers of NEULAND LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| NEULAND LABORATORIES | ₹24,213.0 Cr | 4.7% | 11.3% | 58.7% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹456,989.0 Cr | 1.7% | 6.4% | 12.1% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,471.0 Cr | 3% | 2.8% | 0.9% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹161,290.0 Cr | 2.3% | 9.1% | 44.6% | Stock Analytics | |
| CIPLA | ₹117,820.0 Cr | 0.3% | 6.1% | -3.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹114,730.0 Cr | -0.1% | 8.9% | 1.9% | Stock Analytics | |
NEULAND LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| NEULAND LABORATORIES | 4.7% |
11.3% |
58.7% |
| SENSEX | 0.9% |
4.2% |
-6% |
You may also like the below Video Courses